Equity
AOCI
Gilead Sciences AOCI increased by 100.0% to $78.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.2%, from $92.00M to $78.00M. Over 5 years (FY 2020 to FY 2025), AOCI shows an upward trend with a -8.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
Positive balances indicate unrealized gains in hedges or foreign holdings, while negative balances reflect unrealized losses or unfavorable currency impacts.
Detailed definition
This account accumulates unrealized gains and losses that are excluded from the net income statement, such as foreign cu...
Peer comparison
Highly dependent on the company's global footprint and the extent of its hedging activities against currency and interest rate risks.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $39.00M | $74.00M | $83.00M | $73.00M | $87.00M | $98.00M | $2.00M | -$20.00M | $10.00M | $31.00M | $28.00M | $69.00M | $93.00M | $73.00M | $132.00M | $92.00M | -$18.00M | $36.00M | $39.00M | $78.00M |
| QoQ Change | — | +89.7% | +12.2% | -12.0% | +19.2% | +12.6% | -98.0% | <-999% | +150.0% | +210.0% | -9.7% | +146.4% | +34.8% | -21.5% | +80.8% | -30.3% | -119.6% | +300.0% | +8.3% | +100.0% |
| YoY Change | — | — | — | — | +123.1% | +32.4% | -97.6% | -127.4% | -88.5% | -68.4% | >999% | +445.0% | +830.0% | +135.5% | +371.4% | +33.3% | -119.4% | -50.7% | -70.5% | -15.2% |
Range-$20.00M – $132.00M
CAGR+15.7%
Avg YoY Growth+164.6%
Median YoY Growth+8.6%
Current Streak3 quarters growth
AOCI at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's aoci?
- Gilead Sciences (GILD) reported aoci of $78.00M in Q1 2026.
- How has Gilead Sciences's aoci changed year-over-year?
- Gilead Sciences's aoci decreased by 15.2% year-over-year, from $92.00M to $78.00M.
- What is the long-term trend for Gilead Sciences's aoci?
- Over 5 years (2020 to 2025), Gilead Sciences's aoci has grown at a -8.3% compound annual growth rate (CAGR), from -$60.00M to $39.00M.
- What does aoci mean?
- Cumulative unrealized gains or losses that bypass the income statement, such as currency fluctuations or hedge adjustments.